PACT Antibody

PACT was identified as an activator of PKR, a latent protein kinase that mediates the antiviral actions of interferon. PACT contains 3 double-stranded RNA-binding domains (DRBMs) indicating a role in RNA processing. PACT has been shown to interact with another DRBM-containing protein, TRBP (TAR RNA binding protein), and form a triple complex with Dicer to facilitate the production of siRNA.
PRKRA
protein activator of interferon induced protein kinase EIF2AK2
Interferon-inducible double-stranded RNA-dependent protein kinase activator A
:  DYT16 HSD14 interferon-inducible double stranded RNA-dependent protein kinase activator A PACT PKR-associated protein X PKR-associating protein X protein activator of the interferon-induced protein kinase protein kinase, interferon-inducible double stranded RNA dependent activator protein kinase, interferon-inducible double stranded RNA-dependent activator protein kinase, interferon-inducible double-stranded RNA-dependent activator RAX More... Less...
Product
Specifications
Ordering Information
Human
IP
Between 1 and 50
100
This item is backordered. Please contact Bethyl Customer Support at 1-800-338-9579 if you are interested in purchasing this item. Expected Release early November 2017 (Updated 10/10/2017)
$99
Human
IP
Between 100 and 150
100
This item is backordered. Please contact Bethyl Customer Support at 1-800-338-9579 if you are interested in purchasing this item. Expected Release early November 2017 (Updated 10/10/2017)
$99
Human
100
Includes: 1 each of A302-016A and A302-017A
This item is backordered. Please contact Bethyl Customer Support at 1-800-338-9579 if you are interested in purchasing this item. Expected Release early November 2017 (Updated 10/10/2017)
Includes: 1 each of A302-016A and A302-017A